v3 Template
K

Küleon LLC

Biotechnology/Pharmaceuticals ~135 employees
Founded
--
Employees (Est.)
~135
9 leaders known
Total Funding
$2.0M
Funding Rounds
1
Last Funding
2025-09-23

About Küleon LLC

Küleon is a drug discovery and development company focused on creating novel serotonergic drugs using proprietary AI-based technology for the targeted treatment of various neuropsychiatric diseases and disorders.

Products & Services

Small Molecule Therapeutics:Therapeutics for neuropsychiatric conditions modulated through serotonin receptors in the prefrontal cortex, targeting diseases such as addiction (alcohol, cocaine, nicotine, methamphetamines), schizophrenia, obesity, pain, inflammation, and neurodegeneration.

Specialties

AI-based drug discovery Serotonergic drug development Neuropsychiatric disease treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 2000000
MR: -
FA: $2 million
FAN: 2000000 		D: 2025-09-23
FD: 2025-09-23 		1 investors
Grant Latest
2025-09-23
$2.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

Allen C. Barbieri

Co-Founder, CEO

LinkedIn (Pro only)
J

Jeremy Forest

Co-Founder, CoO

LinkedIn (Pro only)
D

David Gilles

Co-Founder, CTO

LinkedIn (Pro only)
D

Dr. Paul Tarantino

Chief Scientific Officer-ADVISOR

D

Dr. Andy Mattai

Chief Medical Officer

C

Christoph Correll, M.D.

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Küleon LLC Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Pharmaceuticals
Company Size
~135 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro